Registrars: | Capita Registrars |
CEO: | Suzanne Dilly |
CFO: | Gerald Desler |
Executive Director: | Tralau Stewart |
Non-Executive Chairman: | Martin Gouldstone |
Non-Executive Dir: | Adrian de Courcey , Martin Lampshire |
Address: | Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD |
Website: | http://www.valirx.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BLH13C52 |
Currency | UK Pounds |
Share Price | 2.40p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 14.13 |
52 Week Low | 1.90 |
Volume | 203,011 |
Shares Issued | 132.35m |
Market Cap | £3.18m |
RiskGrade | 435 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:08 | 4,226 @ 2.31p |
14:18 | 1,715 @ 2.45p |
14:18 | 1,982 @ 2.32p |
13:56 | 50,000 @ 2.43p |
13:36 | 100,000 @ 2.43p |
You are here: research